ID30046A - Kemoterapi kanker dengan asetildinalina digabung dengan gemsitabina, kapestabina atau kisplatin - Google Patents

Kemoterapi kanker dengan asetildinalina digabung dengan gemsitabina, kapestabina atau kisplatin

Info

Publication number: ID30046A
Authority: ID; Indonesia
Prior art keywords: gemsitabina; capestabine; cancererapy; acethylinineine; cisplatin
Prior art date: 1998-09-25

Application number

IDW20010901A

Other languages

English (en)

Indonesian (id)

Inventor

William R Grove

Wayne D Klohs

Ronald Lynn Merriman

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-25

Filing date

1999-07-08

Publication date

2001-11-01

1999-07-08 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2001-11-01 Publication of ID30046A publication Critical patent/ID30046A/id

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

IDW20010901A 1998-09-25 1999-07-08 Kemoterapi kanker dengan asetildinalina digabung dengan gemsitabina, kapestabina atau kisplatin ID30046A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10180998P	1998-09-25	1998-09-25

Publications (1)

Publication Number	Publication Date
ID30046A true ID30046A (id)	2001-11-01

Family

ID=22286531

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20010901A ID30046A (id)	1998-09-25	1999-07-08	Kemoterapi kanker dengan asetildinalina digabung dengan gemsitabina, kapestabina atau kisplatin

Country Status (34)

Country	Link
US (3)	US6469058B1 (fr)
EP (1)	EP1115391B1 (fr)
JP (1)	JP2002525320A (fr)
KR (1)	KR20010075348A (fr)
CN (1)	CN1319009A (fr)
AP (1)	AP2001002109A0 (fr)
AT (1)	ATE225655T1 (fr)
AU (1)	AU762079B2 (fr)
BG (1)	BG105470A (fr)
BR (1)	BR9913952A (fr)
CA (1)	CA2342981A1 (fr)
CZ (1)	CZ2001905A3 (fr)
DE (1)	DE69903458T2 (fr)
DK (1)	DK1115391T3 (fr)
EA (1)	EA200100369A1 (fr)
EE (1)	EE200100187A (fr)
ES (1)	ES2185378T3 (fr)
GE (1)	GEP20043199B (fr)
HK (1)	HK1040190A1 (fr)
HR (1)	HRP20010225B1 (fr)
HU (1)	HUP0103640A3 (fr)
ID (1)	ID30046A (fr)
IL (1)	IL141951A0 (fr)
IS (1)	IS5888A (fr)
NO (1)	NO20011493L (fr)
NZ (1)	NZ510504A (fr)
OA (1)	OA11659A (fr)
PL (1)	PL348673A1 (fr)
PT (1)	PT1115391E (fr)
SK (1)	SK3602001A3 (fr)
TR (1)	TR200100859T2 (fr)
WO (1)	WO2000018393A1 (fr)
YU (1)	YU22401A (fr)
ZA (1)	ZA200102233B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ID30046A (id) *	1998-09-25	2001-11-01	Warner Lambert Co	Kemoterapi kanker dengan asetildinalina digabung dengan gemsitabina, kapestabina atau kisplatin
CZ20022216A3 (cs) *	2001-07-02	2003-05-14	Warner-Lambert Company	Kombinační chemoterapie
CA2383259A1 (fr)	2002-04-23	2003-10-23	Celator Technologies Inc.	Composes synergiques
US20080075762A1 (en) *	2001-10-03	2008-03-27	Paul Tardi	Compositions for delivery of drug combinations
US7850990B2 (en) *	2001-10-03	2010-12-14	Celator Pharmaceuticals, Inc.	Compositions for delivery of drug combinations
US7456219B2 (en) *	2002-03-04	2008-11-25	Merck Hdac Research, Llc	Polymorphs of suberoylanilide hydroxamic acid
US20040132825A1 (en) *	2002-03-04	2004-07-08	Bacopoulos Nicholas G.	Methods of treating cancer with HDAC inhibitors
PL372239A1 (en) *	2002-03-04	2005-07-11	Aton Pharma, Inc.	Methods of inducing terminal differentiation
JP2005530734A (ja) *	2002-04-15	2005-10-13	スローン − ケッタリングインスティチュートフォーキャンサーリサーチ	癌の処置のための併用療法
US20070032422A1 (en)	2002-10-24	2007-02-08	Spectrum Pharmaceuticals, Inc.	Methods, compositions and articles of manufacture for contributing to the treatment of cancers
US8026216B2 (en)	2002-10-24	2011-09-27	Spectrum Pharmaceuticals, Inc.	Methods and compositions for contributing to the treatment of cancers
GB0226434D0 (en) *	2002-11-13	2002-12-18	Astrazeneca Ab	Combination product
BR0316238A (pt) *	2002-11-15	2005-10-11	Warner Lambert Co	Quimioterapia de associação compreendendo um inibidor de mek e capecitabina para tratamento de câncer
RU2240117C1 (ru) *	2003-04-01	2004-11-20	Алтайский государственный медицинский университет	Способ лечения больных с местнораспространенными формами плоскоклеточного рака с локализацией в области слизистой оболочки полости рта и ротового отдела глотки
WO2005000266A2 (fr) *	2003-05-22	2005-01-06	Neopharm, Inc.	Formulations liposomales combinees
PE20050206A1 (es) *	2003-05-26	2005-03-26	Schering Ag	Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
CN100431606C (zh) *	2004-11-22	2008-11-12	山东蓝金生物工程有限公司	一种抗癌药物组合物
US7957507B2 (en)	2005-02-28	2011-06-07	Cadman Patrick F	Method and apparatus for modulating a radiation beam
CN100443081C (zh) *	2005-04-05	2008-12-17	吴一心	木犀草素与一种铂类化疗药物联合用于制备抗肿瘤的药物
US8232535B2 (en)	2005-05-10	2012-07-31	Tomotherapy Incorporated	System and method of treating a patient with radiation therapy
EP1907984A4 (fr)	2005-07-22	2009-10-21	Tomotherapy Inc	Procede et systeme de traitement de donnees relatives a un plan de traitement par radiotherapie
US8442287B2 (en)	2005-07-22	2013-05-14	Tomotherapy Incorporated	Method and system for evaluating quality assurance criteria in delivery of a treatment plan
AU2006272746A1 (en)	2005-07-22	2007-02-01	Tomotherapy Incorporated	Method and system for evaluating delivered dose
US7639853B2 (en)	2005-07-22	2009-12-29	Tomotherapy Incorporated	Method of and system for predicting dose delivery
EP1907968A4 (fr) *	2005-07-22	2009-10-21	Tomotherapy Inc	Methode et systeme pour evaluer des criteres d'assurance qualite concernant un programme d'administration de traitement
JP2009507524A (ja)	2005-07-22	2009-02-26	トモセラピー・インコーポレーテッド	変形マップに制約を課す方法およびそれを実装するためのシステム
ATE507879T1 (de)	2005-07-22	2011-05-15	Tomotherapy Inc	System zur verabreichung einer strahlentherapie auf ein sich bewegendes zielgebiet
ATE511885T1 (de)	2005-07-22	2011-06-15	Tomotherapy Inc	Verfahren zur bestimmung eines interessierenden bereiches von oberflächenstrukturen mit einem dosiervolumenhistogramm
US8767917B2 (en)	2005-07-22	2014-07-01	Tomotherapy Incorpoated	System and method of delivering radiation therapy to a moving region of interest
KR20080039920A (ko)	2005-07-22	2008-05-07	토모테라피 인코포레이티드	방사선 치료 시스템에 의해 부여되는 선량을 평가하는시스템 및 방법
JP2009502252A (ja)	2005-07-22	2009-01-29	トモセラピー・インコーポレーテッド	生物学的モデルに基づいて放射線療法治療プランを適合させるための方法およびシステム
AU2006272821A1 (en)	2005-07-23	2007-02-01	Tomotherapy Incorporated	Radiation therapy imaging and delivery utilizing coordinated motion of gantry and couch
EP2059254B1 (fr) *	2006-08-31	2015-04-08	Spectrum Pharmaceuticals, Inc.	Sensibilisation de cellules tumorales à la radiothérapie par administration d'agonistes d'endothéline
CN101969963A (zh) *	2008-01-28	2011-02-09	那野伽利阿株式会社	医药组合物或组合剂
FR2937867B1 (fr) *	2008-11-03	2011-03-04	Biorebus	Association pharmaceutique contenant l acide lipoique et l acide hydroxycitrique a titre de principes actifs.
CA2757743C (fr)	2009-04-06	2017-10-10	Eisai Inc.	Derives de (2'-desoxy-ribofuranosyl)-1,3,4,7-tetrahydro-(1,3) diazepine-2-0ne pour le traitement du cancer
WO2012003413A1 (fr) *	2010-06-30	2012-01-05	The Broad Institute, Inc.	Nouvelles formes solides de tacédinaline
US8729130B2 (en)	2011-07-01	2014-05-20	The Broad Institute, Inc.	Methods of using novel solid forms of tacedinaline
US9308235B2 (en)	2012-05-09	2016-04-12	Spectrum Pharmaceuticals, Inc.	Treatment of primary and metastatic carcinoma
EP2711007A1 (fr)	2012-09-19	2014-03-26	Institut Univ. de Ciència i Tecnologia, S.A.	4-Aminopyrazolo[3,4-d]pyrimidine destiné à être utilisé dans le traitement ou la prévention du cancer du sein et de la prostate primitif et métastatique
EP2711009A1 (fr)	2012-09-19	2014-03-26	Institut Univ. de Ciència i Tecnologia, S.A.	Composés destinés à être utilisés dans le traitement ou la prévention du cancer primitif et métastatique du sein et de la prostate
EP2711008A1 (fr)	2012-09-19	2014-03-26	Institut Univ. de Ciència i Tecnologia, S.A.	N6,N6-dimethyladenosine destiné à être utilisé dans le traitement ou la prévention du cancer du sein primitif et métastatique
WO2014133849A2 (fr)	2013-02-26	2014-09-04	Accuray Incorporated	Collimateur multilame actionné par voie électromagnétique
US10189797B2 (en) *	2015-12-30	2019-01-29	Duke University	Chemical modulators of immune checkpoints and therapeutic use
US11987579B2 (en)	2018-07-30	2024-05-21	Duke University	Niclosamide analogues and therapeutic use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5562925A (en) *	1970-04-20	1996-10-08	Research Corporation Tech. Inc.	Anti-tumor method
NZ219974A (en) *	1986-04-22	1989-08-29	Goedecke Ag	N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
AU671491B2 (en) *	1992-12-18	1996-08-29	F. Hoffmann-La Roche Ag	N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
AU6878198A (en)	1997-04-24	1998-11-13	Warner-Lambert Company	Use of acetyldinaline for the manufacture of a medicament for the treatment of renal cell carcinoma
US5972986A (en) *	1997-10-14	1999-10-26	G.D. Searle & Co.	Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
ID30046A (id) *	1998-09-25	2001-11-01	Warner Lambert Co	Kemoterapi kanker dengan asetildinalina digabung dengan gemsitabina, kapestabina atau kisplatin

1999
- 1999-07-08 ID IDW20010901A patent/ID30046A/id unknown
- 1999-07-08 IL IL14195199A patent/IL141951A0/xx unknown
- 1999-07-08 PL PL99348673A patent/PL348673A1/xx not_active Application Discontinuation
- 1999-07-08 GE GEAP19995872A patent/GEP20043199B/en unknown
- 1999-07-08 DK DK99935442T patent/DK1115391T3/da active
- 1999-07-08 AT AT99935442T patent/ATE225655T1/de not_active IP Right Cessation
- 1999-07-08 BR BR9913952-9A patent/BR9913952A/pt not_active IP Right Cessation
- 1999-07-08 HK HK02101589.3A patent/HK1040190A1/zh unknown
- 1999-07-08 ES ES99935442T patent/ES2185378T3/es not_active Expired - Lifetime
- 1999-07-08 NZ NZ510504A patent/NZ510504A/en unknown
- 1999-07-08 HU HU0103640A patent/HUP0103640A3/hu unknown
- 1999-07-08 TR TR2001/00859T patent/TR200100859T2/xx unknown
- 1999-07-08 PT PT99935442T patent/PT1115391E/pt unknown
- 1999-07-08 CN CN99811320A patent/CN1319009A/zh active Pending
- 1999-07-08 WO PCT/US1999/015386 patent/WO2000018393A1/fr not_active Ceased
- 1999-07-08 EE EEP200100187A patent/EE200100187A/xx unknown
- 1999-07-08 KR KR1020017003794A patent/KR20010075348A/ko not_active Withdrawn
- 1999-07-08 SK SK360-2001A patent/SK3602001A3/sk unknown
- 1999-07-08 YU YU22401A patent/YU22401A/sh unknown
- 1999-07-08 US US09/744,130 patent/US6469058B1/en not_active Expired - Fee Related
- 1999-07-08 OA OA1200100078A patent/OA11659A/en unknown
- 1999-07-08 CZ CZ2001905A patent/CZ2001905A3/cs unknown
- 1999-07-08 AP APAP/P/2001/002109A patent/AP2001002109A0/en unknown
- 1999-07-08 DE DE69903458T patent/DE69903458T2/de not_active Expired - Fee Related
- 1999-07-08 CA CA002342981A patent/CA2342981A1/fr not_active Abandoned
- 1999-07-08 AU AU50921/99A patent/AU762079B2/en not_active Ceased
- 1999-07-08 JP JP2000571912A patent/JP2002525320A/ja active Pending
- 1999-07-08 EP EP99935442A patent/EP1115391B1/fr not_active Expired - Lifetime
- 1999-07-08 HR HR20010225A patent/HRP20010225B1/xx not_active Application Discontinuation
- 1999-07-08 EA EA200100369A patent/EA200100369A1/ru unknown
2001
- 2001-03-14 IS IS5888A patent/IS5888A/is unknown
- 2001-03-16 ZA ZA200102233A patent/ZA200102233B/en unknown
- 2001-03-23 NO NO20011493A patent/NO20011493L/no not_active Application Discontinuation
- 2001-04-25 BG BG105470A patent/BG105470A/xx unknown
2002
- 2002-10-08 US US10/184,309 patent/US20030170300A1/en not_active Abandoned
- 2002-10-09 US US10/185,221 patent/US20030086965A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ATE225655T1 (de)	2002-10-15
DE69903458D1 (de)	2002-11-14
AU5092199A (en)	2000-04-17
GEP20043199B (en)	2004-03-25
BG105470A (en)	2001-12-29
YU22401A (sh)	2004-03-12
OA11659A (en)	2004-12-08
HK1040190A1 (zh)	2002-05-31
CZ2001905A3 (cs)	2001-08-15
CN1319009A (zh)	2001-10-24
DE69903458T2 (de)	2003-07-10
CA2342981A1 (fr)	2000-04-06
AU762079B2 (en)	2003-06-19
HUP0103640A3 (en)	2003-01-28
IL141951A0 (en)	2002-03-10
PT1115391E (pt)	2003-02-28
HRP20010225B1 (en)	2004-10-31
KR20010075348A (ko)	2001-08-09
US6469058B1 (en)	2002-10-22
HRP20010225A2 (en)	2002-04-30
TR200100859T2 (tr)	2001-08-21
PL348673A1 (en)	2002-06-03
EA200100369A1 (ru)	2001-10-22
HUP0103640A2 (en)	2002-06-29
EP1115391B1 (fr)	2002-10-09
EP1115391A1 (fr)	2001-07-18
JP2002525320A (ja)	2002-08-13
DK1115391T3 (da)	2003-02-10
ES2185378T3 (es)	2003-04-16
NO20011493L (no)	2001-05-23
AP2001002109A0 (en)	2001-03-31
SK3602001A3 (en)	2002-07-02
US20030086965A1 (en)	2003-05-08
US20030170300A1 (en)	2003-09-11
NO20011493D0 (no)	2001-03-23
IS5888A (is)	2001-03-14
EE200100187A (et)	2002-08-15
ZA200102233B (en)	2002-06-18
NZ510504A (en)	2003-09-26
WO2000018393A1 (fr)	2000-04-06
BR9913952A (pt)	2001-06-12

Publication	Publication Date	Title
ID30046A (id)	2001-11-01	Kemoterapi kanker dengan asetildinalina digabung dengan gemsitabina, kapestabina atau kisplatin
LU93311I2 (fr)	2017-01-26	Mancozèbe, valifenalate
CU23049A3 (es)	2005-06-24	Dihidropirimidinas.
IT1307274B1 (it)	2001-10-30	Fibbia.
IT1312540B1 (it)	2002-04-22	Composto.
IT1307057B1 (it)	2001-10-23	Fibbia.
IS5969A (is)	2001-06-14	Samsett lyfjameðferð
NL1013360A1 (nl)	1999-11-17	Bouwkundige afscherming.
ID26184A (id)	2000-12-07	Hidrogenase alfa, omega-dinitril alifatik
IT1306882B1 (it)	2001-10-11	Innesto elettromagnetico.
DE69805858D1 (de)	2002-07-11	Geschlossene wulstkonstruktion
NO995727D0 (no)	1999-11-22	Baereanordning
IT1304039B1 (it)	2001-03-02	Gommatore.
BR9908946B1 (pt)	2009-05-05	forração.
IT1308896B1 (it)	2002-01-11	Innesto elettromagnetico.
NO981034L (no)	1999-09-10	Kokeapparat
ES1040892Y (es)	1999-10-01	Luminaria empotrable.
ES1041377Y (es)	1999-11-16	Lampara.
ES1041087Y (es)	1999-10-16	Lampara.
ES1039687Y (es)	1999-06-01	Linterna.
ES1040945Y (es)	1999-10-01	Cocedor.
ES1042117Y (es)	2000-01-01	Mesa-sombrilla.
ES1040589Y (es)	1999-08-16	Expositor-dispensador.
ES1040633Y (es)	1999-10-01	Escalifono.
ES1039730Y (es)	1999-06-01	Rodapie.